ProfileGDS4718 / 238833_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 5% 9% 19% 7% 6% 37% 15% 10% 13% 5% 7% 2% 10% 40% 18% 10% 11% 18% 17% 14% 7% 8% 19% 8% 3% 16% 6% 44% 4% 12% 9% 30% 3% 3% 17% 54% 9% 10% 7% 20% 7% 14% 17% 44% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.604535
GSM549102patient 115, normal, homogenized [OPG study]3.758159
GSM549104patient 119, normal, homogenized [OPG study]4.0958219
GSM549108patient 138, normal, homogenized [OPG study]3.676857
GSM549119patient 077, normal, homogenized [OPG study]3.614766
GSM549133patient 032, cancer, homogenized [OPG study]4.8005237
GSM549139patient 042, cancer, homogenized [OPG study]3.9361915
GSM549099patient 107, normal, homogenized [OPG study]3.7844910
GSM549109patient 139, normal, homogenized [OPG study]3.9048513
GSM549110patient 046, normal, homogenized [OPG study]3.602765
GSM549114patient 063, normal, homogenized [OPG study]3.635417
GSM549122patient 082, normal, homogenized [OPG study]3.41892
GSM549134patient 033, cancer, homogenized [OPG study]3.7849610
GSM549136patient 036, cancer, homogenized [OPG study]4.9276740
GSM549140patient 044, cancer, homogenized [OPG study]4.0281218
GSM549111patient 047, normal, homogenized [OPG study]3.7406510
GSM549113patient 057, normal, homogenized [OPG study]3.7945111
GSM549132patient 031, cancer, homogenized [OPG study]4.0608118
GSM549137patient 038, cancer, homogenized [OPG study]4.0167217
GSM549142patient 047, cancer, homogenized [OPG study]3.9844314
GSM549100patient 110, normal, homogenized [OPG study]3.668647
GSM549107patient 135, normal, homogenized [OPG study]3.702728
GSM549115patient 068, normal, homogenized [OPG study]4.064319
GSM549116patient 072, normal, homogenized [OPG study]3.692378
GSM549120patient 078, normal, homogenized [OPG study]3.500423
GSM549131patient 030, cancer, homogenized [OPG study]3.9514316
GSM549118patient 074, normal, homogenized [OPG study]3.646996
GSM549129patient 027, cancer, homogenized [OPG study]5.2165844
GSM549123patient 088, normal, homogenized [OPG study]3.566874
GSM549124patient 006, cancer, homogenized [OPG study]3.8912
GSM549126patient 015, cancer, homogenized [OPG study]3.717079
GSM549128patient 025, cancer, homogenized [OPG study]4.5110830
GSM549103patient 117, normal, homogenized [OPG study]3.522453
GSM549117patient 073, normal, homogenized [OPG study]3.507633
GSM549138patient 041, cancer, homogenized [OPG study]4.0313717
GSM549141patient 045, cancer, homogenized [OPG study]5.7313654
GSM549130patient 028, cancer, homogenized [OPG study]3.766129
GSM549101patient 111, normal, homogenized [OPG study]3.7747410
GSM549105patient 128, normal, homogenized [OPG study]3.686237
GSM549106patient 134, normal, homogenized [OPG study]4.0996620
GSM549112patient 048, normal, homogenized [OPG study]3.674927
GSM549125patient 011, cancer, homogenized [OPG study]3.9403814
GSM549127patient 024, cancer, homogenized [OPG study]4.0128317
GSM549135patient 035, cancer, homogenized [OPG study]5.1258244